BCAN Antikörper (AA 23-911)
Kurzübersicht für BCAN Antikörper (AA 23-911) (ABIN602839)
Target
Alle BCAN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 23-911
-
Spezifität
- Recognizes human Brevican.
-
Aufreinigung
- Protein G purified
-
Immunogen
- NS0-derived rhBrevican. (aa 23 - 911).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Approved: ELISA (0.5 - 1 μg/mL), Func, IP (25 μg/mL), WB (1 - 2 μg/mL)
Usage: Suitable for use in Direct ELISA, Western Blot and Immunoprecipitation. Direct ELISA: 0.5-1.0 μg/mL detection limit for rhBrevican is ~1 ng/well. Western Blot: 1-2 μg/mL detection limit for rhBrevican is ~10 ng/lane under non-reducing conditions. Immunoprecipitation: 25 μg/mL. Blocking of receptor-ligand interaction: ~0.01 to 0.05 μg/mL of this antibody will block 50 % of the binding of 1 μg/mL of Hyaluronan (132kD) to immobilized rhBrevican (100 μL of a 3 μg/mL solution was coated in each well) in a functional ELISA. At 1 μg/mL, this antibody will achieve 100 % blocking in the assay. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Sterile PBS
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS, 5 % trehalose
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Lyophilized powder may be stored at -20°C. Reconstituted product is stable for 1 year at -20°C.
-
-
- BCAN (Brevican (BCAN))
-
Andere Bezeichnung
- BCAN / Brevican
-
Hintergrund
-
Name/Gene ID: BCAN
Synonyms: BCAN, Brevican, BEHAB, CSPG7, Brevican core protein -
Gen-ID
- 63827
-
UniProt
- Q96GW7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-